Pediatric new-onset super refractory status epilepticus: Potential of timely immunotherapy in a resource-limited PICU
Aakash Chandran Chidambaram1, Jerin C Sekhar1, Suresh Kumar Angurana1
1Division of Pediatric Critical Care.
Insights
Pediatric new-onset super-refractory status epilepticus (NOSRSE) can have favorable outcomes with early immunotherapy improving survival. Protocolized care is crucial, especially in resource-limited settings for these severe pediatric epilepsy cases.
Area of Science:
- Pediatric Neurology
- Critical Care Medicine
- Epileptology
Background:
- New-onset super-refractory status epilepticus (NOSRSE) is a severe neurological emergency in children.
- Understanding its clinical profile, management, and outcomes is vital for improving patient care.
Purpose of the Study:
- To describe the clinical characteristics, management strategies, and outcomes of pediatric NOSRSE.
- To identify factors predicting survival in children with NOSRSE.
Main Methods:
- Retrospective observational study of 36 children with NOSRSE in a Pediatric Intensive Care Unit.
- Analysis of clinical data, neurodiagnostic findings, treatments, and outcomes.
- Univariate logistic regression to determine survival predictors.
Main Results:
- The median age was 8 years, with 63.9% males. Etiology remained unknown in 77.7% of cases.
- MRI abnormalities and non-convulsive seizures on EEG were common (72.7% and 55.6%, respectively).
- Seizure control was achieved in 80.6%, with a 72.2% survival rate. Early immunotherapy was linked to better survival (OR 0.83).
Conclusions:
- Favorable outcomes are achievable in pediatric NOSRSE despite illness severity.
- Early immunotherapy is associated with improved survival rates.
- Time-sensitive, protocolized care is essential for pediatric NOSRSE, particularly in resource-limited environments.
Purpose:
To describe the clinical profile, management, and outcomes of children with new-onset super-refractory status epilepticus (NOSRSE), and to identify predictors of survival.
Method:
This was a retrospective observational study conducted in the Pediatric Intensive Care Unit at PGIMER, Chandigarh, India, from January 2019 to August 2024. Thirty-six children diagnosed with NORSE who progressed to super-refractory status epilepticus were included. Clinical characteristics, neurodiagnostic findings, treatment details, and outcomes were analyzed. Univariate logistic regression was used to identify predictors of survival.
Results:
Median age was 8 years; 63.9 % were male. No etiology was identified in 28 (77.7 %) children, autoimmune encephalitis in 5 (13.9 %) and viral encephalitis in 3 (8.3 %) children. MRI abnormalities were seen in 72.7 %, and non-convulsive seizures on EEG in 55.6 %. Seizure control was achieved in 80.6 %, and 72.2 % survived to hospital discharge. Median PCPC score improved from 5 at discharge to 3 at 6-month follow-up. Early immunotherapy (OR 0.83; 95 % CI (0.69, 0.99); p 0.04) was associated with better survival.
Conclusion:
Despite the severity of illness, favorable outcomes were achievable. Early immunotherapy was associated with improved survival. These findings underscore the need for time-sensitive, protocolized care in pediatric NOSRSE, especially in resource-limited settings.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Limiting Reactant
Short-distance Transport of Resources
The Number e as a Limit
Types of Limits I
Limit Laws I


